Definitive Contract 75N93023C00019
Award Date 6/1/23
Potential Completion Date 5/31/26
Potential Value $23M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
New York, NY 10029, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
19
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $9,013,936.11 cost-no-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to the Icahn School of Medicine at Mount Sinai. The contract is part of NIAID's Vaccine Adjuvant Discovery Program and aims to identify novel adjuvant candidates that can be used to enhance the efficacy of human vaccines. The contract has no set-aside designation. Key subcontractors include The Scripps Research Institute,...
- This federal contract award to the Icahn School of Medicine at Mount Sinai (ISMMS) was made by the National Institute of Allergy and Infectious Diseases (NIAID) to conduct research on "Modeling Immunity for Biodefense". The $17,219,467.21 cost-no-fee contract has a period of performance from September 30, 2010 to September 29, 2015 and does not have a set-aside designation. Under this award, ISMMS is collaborating with several subcontractors, including the California Institute of...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $42,132,619.00 definitive contract to the Icahn School of Medicine at Mount Sinai (ISMMS) for the NIAID Centers of Excellence for Influenza Research and Surveillance program. This cost-no-fee contract, awarded on March 30, 2007, has a performance period ending on May 23, 2017. ISMMS, a private university and non-profit organization, will...
- This federal contract award is to the Icahn School of Medicine at Mount Sinai (ISMMS), a renowned academic medical center and research institution in New York City. The contract, valued at $399,266.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to support the development of animal models of infectious diseases. The award is a delivery order under NIAID's larger "Animal Models of Infectious Diseases...
- This federal contract award is for the "MODELING IMMUNITY FOR BIODEFENSE" program, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the Icahn School of Medicine at Mount Sinai (ISMMS), a private non-profit educational institution. The award is a $23,517,489.00 definitive contract with a cost-no-fee pricing type, with a period of performance from September 29, 2005 to September 29, 2010. The contract does not have a set-aside designation. ISMMS, a renowned...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $151.4 million cost-no-fee definitive contract to Icahn School of Medicine at Mount Sinai to support Component A of the Collaborative Influenza Vaccine Innovation Centers (CIVICS) program. The contract, awarded September 10, 2019, with performance extending through February 28, 2027, funds research to design and evaluate innovative influenza vaccine approaches based on principles of influenza immunity to achieve durable,...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the Icahn School of Medicine at Mount Sinai (ISMMS), a private university and non-profit educational institution. The $10,799,605.00 Definitive Contract is for BIOMEDICAL (BASIC) services, with a Firm Fixed Price pricing type. The contract has no set-aside designation and was awarded on August 17, 2009, with a completion date of September...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the Icahn School of Medicine at Mount Sinai (ISMMS), a private academic medical center and research institution located in New York, NY. The $18,691,713.00 cost-no-fee definitive contract is for biomedical research services, with a period of performance ending on March 31, 2011. The contract does not have a set-aside designation....
- This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to the University of Maryland, Baltimore (UMB) on April 10, 2015 and has a ceiling value of $882,112.66. It is a task order under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Vehicle (IDV), which allows NIAID to place orders for medical research and services...
- This federal contract award, valued at $121,633.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the Icahn School of Medicine at Mount Sinai (ISMMS) for the development of mouse models to support research on low pathogenic seasonal and pandemic influenza viruses. The period of performance is from September 9, 2013, through September 8, 2014, with a final completion date of May 8, 2015. This award is a delivery order under the NIAID Animal Models of...